BOLT: Bolt Biotherapeutics, Inc. Common Stock Company Profile & Statistics

About

Bolt Biotherapeutics Inc. is a clinical-stage immuno-oncology company. It engages in the discovery, development, and commercialization of pharmaceutical products. The company's principal product includes BDC-1001. Bolt Biotherapeutics Inc. is based in Redwood city, California.

Info & Links

CEO

Randall C. Schatzman

Headquarters

900 CHESAPEAKE DRIVE
REDWOOD CITY, CA 94063, UNITED STATES

Auditor

PricewaterhouseCoopers LLP

Share holders

Employees

100

Bolt Biotherapeutics, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization²

15.14M

Enterprise Value

20.34M

Enterprise Value/EBITDA(ttm)

-0.26

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

2.00

Price to Book(mrq)

0.27

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

75.00%

Operating Margin(ttm)

-665.56%

Profit Margin(ttm)

-799.35%

Return on Equity(ttm)

-69.46%

Return on Invested Capital(ttm)

-67.02%

Return on Assets(ttm)

-48.55%

Income Statement

Revenue(ttm)

9.78M

Revenue Per Share(ttm)

0.26

Gross Profit(ttm)

9.78M

EBITDA(ttm)³

-77.58M

Net Income Available to Common(ttm)

-65.09M

Diluted EPS(ttm)

-1.71

Share Statistics

Beta (5Y Monthly)

0.95

52-Week Change

-73.33%

S&P 500 52-Week Change

-2.50%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

38.27M

Dividend Yield

0.00%

Float⁴

26.45M

% Held by Insiders

30.90%

% Held by Institutions

86.70%

Balance Sheet

Total Cash(mrq)

54.59M

Total Cash Per Share(mrq)

1.43

Total Debt(mrq)

15.35M

Total Debt/Equity(mrq)

40.14%

Current Ratio(mrq)

3.20%

Quick Ratio(mrq)

3.16%

Book Value Per Share(mrq)

1.49

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.61

Free Cash Flow(ytd)

-61.18M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

BOLT

Bolt Biotherapeutics, Inc. Common Stock

Bolt Biotherapeutics, Inc. Common Stock Profile